Literature DB >> 35324346

Defining Clinical Utility of Germline Indicators of Toxicity Risk: A Perspective.

Daniel L Hertz1, Lisa M McShane2, Daniel F Hayes3.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35324346      PMCID： PMC9148690          DOI： 10.1200/JCO.21.02209

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   50.717


× No keyword cloud information.
  68 in total

1.  Thiopurine methyltransferase in acute lymphoblastic leukemia.

Authors:  Mary V Relling; Ching-Hon Pui; Cheng Cheng; William E Evans
Journal:  Blood       Date:  2006-01-15       Impact factor: 22.113

2.  Pharmacogenomics: "noninferiority" is sufficient for initial implementation.

Authors:  R B Altman
Journal:  Clin Pharmacol Ther       Date:  2011-03       Impact factor: 6.875

3.  Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

Authors:  Sara M Tolaney; William T Barry; Chau T Dang; Denise A Yardley; Beverly Moy; P Kelly Marcom; Kathy S Albain; Hope S Rugo; Matthew Ellis; Iuliana Shapira; Antonio C Wolff; Lisa A Carey; Beth A Overmoyer; Ann H Partridge; Hao Guo; Clifford A Hudis; Ian E Krop; Harold J Burstein; Eric P Winer
Journal:  N Engl J Med       Date:  2015-01-08       Impact factor: 91.245

4.  Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.

Authors:  Mary V Relling; Matthias Schwab; Michelle Whirl-Carrillo; Guilherme Suarez-Kurtz; Ching-Hon Pui; Charles M Stein; Ann M Moyer; William E Evans; Teri E Klein; Federico Guillermo Antillon-Klussmann; Kelly E Caudle; Motohiro Kato; Allen E J Yeoh; Kjeld Schmiegelow; Jun J Yang
Journal:  Clin Pharmacol Ther       Date:  2019-01-20       Impact factor: 6.875

Review 5.  Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy.

Authors:  Jan H Beumer; Edward Chu; Carmen Allegra; Yusuke Tanigawara; Gerard Milano; Robert Diasio; Tae Won Kim; Ron H Mathijssen; Li Zhang; Dirk Arnold; Katsuki Muneoka; Narikazu Boku; Markus Joerger
Journal:  Clin Pharmacol Ther       Date:  2018-09-11       Impact factor: 6.875

6.  Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy: Progress Continues.

Authors:  Barthelemy Diouf; William E Evans
Journal:  Clin Pharmacol Ther       Date:  2018-09-16       Impact factor: 6.875

Review 7.  Abacavir pharmacogenetics--from initial reports to standard of care.

Authors:  Michael A Martin; Deanna L Kroetz
Journal:  Pharmacotherapy       Date:  2013-05-03       Impact factor: 4.705

8.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors:  R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal:  Lancet       Date:  2011-12-05       Impact factor: 79.321

9.  Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer.

Authors:  Hironori Fujii; Yunami Yamada; Daichi Watanabe; Nobuhisa Matsuhashi; Takao Takahashi; Kazuhiro Yoshida; Akio Suzuki
Journal:  Cancer Chemother Pharmacol       Date:  2018-10-30       Impact factor: 3.333

10.  Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.

Authors:  Julio D Duarte; Rachel Dalton; Amanda L Elchynski; D Max Smith; Emily J Cicali; James C Lee; Benjamin Q Duong; Natasha J Petry; Christina L Aquilante; Amber L Beitelshees; Philip E Empey; Julie A Johnson; Aniwaa Owusu Obeng; Amy L Pasternak; Victoria M Pratt; Laura B Ramsey; Sony Tuteja; Sara L Van Driest; Kristin Wiisanen; J Kevin Hicks; Larisa H Cavallari
Journal:  Genet Med       Date:  2021-07-19       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.